Strengthening MedTech Evidence Generation: Franklyn Health and Mantra Systems
In today’s MedTech landscape, the demand for robust, reproducible clinical evidence has never been greater. Regulatory bodies are raising the bar, investors are scrutinising data quality, and sponsors need CRO partners who can navigate complexity without slowing momentum. For Franklyn Health, deepening its expertise in the MedTech CRO space means aligning with technology partners who share that same commitment to rigour. That’s why the partnership with Mantra Systems is a natural fit.
Mantra Systems brings focused, practical expertise in EU MDR, FDA and IVDR compliance, helping MedTech manufacturers build the clinical and regulatory foundations their devices need to reach and stay on the market. Their work sits at the intersection of regulatory strategy and evidence generation – exactly the terrain Franklyn Health is increasingly operating in.
Regulatory Expertise That Complements Clinical Research
One of the persistent challenges in MedTech development is the gap between clinical data generation and regulatory submission. Studies are designed, data is collected, and then the translation into compliant documentation becomes a bottleneck. Franklyn Health is building its understanding of how to close that gap earlier in the process, and Mantra Systems’ deep knowledge of clinical evaluation, Post-Market Clinical Follow-Up (PMCF), and technical documentation provides a valuable reference point.
For sponsors working toward CE marking or maintaining compliance under EU MDR, having a CRO that understands the regulatory destination — not just the data collection process — makes a measurable difference to study design and execution.
Shared Focus on Post-Market Clinical Follow-Up
PMCF has become one of the most active areas of MedTech clinical research, and it’s an area where Franklyn Health continues to develop its capabilities. Mantra Systems has built a clear methodology around PMCF planning and execution, which aligns with the growing demand Franklyn Health sees from sponsors needing structured, ongoing evidence programmes rather than one-off studies.
As regulatory expectations around real-world evidence and continuous post-market surveillance increase, the ability to design PMCF studies that satisfy both clinical and regulatory requirements is fast becoming a core competency for any serious MedTech CRO.
A Partnership Built on Evidence
Franklyn Health and Mantra Systems share a foundational belief: that high-quality clinical evidence is not just a compliance obligation, but a strategic asset for any MedTech company navigating today’s regulatory environment. By expanding its knowledge of EU MDR frameworks and regulatory evidence requirements, Franklyn Health is better positioned to support sponsors from early study design through to market access and beyond.
